Skip to main content

Table 2 Duration between day of hospitalization and start of moxifloxacin therapy (efficacy population)

From: Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)

Duration (days)

Total N = 2152 (100.0%)

n

(%)

0

1840

(85.5)

1

107

(5.0)

2

55

(2.6)

3

46

(2.1)

4

32

(1.5)

5

36

(1.7)

6

34

(1.1)

Missing

12

(0.6)